EP1011567A4 - Arzneistoffabgabesysteme und verfahren zur behandlung viraler und mikrobieller infektionen und des abmagerungssyndroms - Google Patents

Arzneistoffabgabesysteme und verfahren zur behandlung viraler und mikrobieller infektionen und des abmagerungssyndroms

Info

Publication number: EP1011567A4
Authority: EP; European Patent Office
Prior art keywords: syndrome; loss; methods; drug delivery; delivery devices
Prior art date: 1997-06-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98926488A

Other languages

English (en)

French (fr)

Other versions

EP1011567A1 (de

Inventor

Michelle Olga Patricia Visser

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

VIRODENE PHARMACEUTICAL HOLDINGS (PTY) LTD.

Original Assignee

Cryopreservation Technologies CC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-13

Filing date

1998-06-09

Publication date

2000-06-28

1997-06-13 Priority claimed from US08/874,425 external-priority patent/US5935597A/en

1998-06-09 Application filed by Cryopreservation Technologies CC filed Critical Cryopreservation Technologies CC

2000-06-28 Publication of EP1011567A4 publication Critical patent/EP1011567A4/de

2000-06-28 Publication of EP1011567A1 publication Critical patent/EP1011567A1/de

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Medical Informatics (AREA)
Anesthesiology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EP98926488A 1997-06-13 1998-06-09 Arzneistoffabgabesysteme und verfahren zur behandlung viraler und mikrobieller infektionen und des abmagerungssyndroms Withdrawn EP1011567A1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/874,425 US5935597A (en)	1995-12-15	1997-06-13	Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en)	1997-06-13	1998-06-09	Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
US874425		2001-06-04

Publications (2)

Publication Number	Publication Date
EP1011567A4 true EP1011567A4 (de)	2000-06-28
EP1011567A1 EP1011567A1 (de)	2000-06-28

Family

ID=25363728

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98926488A Withdrawn EP1011567A1 (de)	1997-06-13	1998-06-09	Arzneistoffabgabesysteme und verfahren zur behandlung viraler und mikrobieller infektionen und des abmagerungssyndroms

Country Status (34)

Country	Link
EP (1)	EP1011567A1 (de)
JP (1)	JP4531141B2 (de)
KR (1)	KR20010013709A (de)
CN (1)	CN1260703A (de)
AP (1)	AP1629A (de)
AR (1)	AR012970A1 (de)
AU (1)	AU7831598A (de)
BG (1)	BG103997A (de)
BR (1)	BR9810095A (de)
CA (1)	CA2295176A1 (de)
CZ (1)	CZ298510B6 (de)
EA (1)	EA200000011A1 (de)
EE (1)	EE9900562A (de)
ES (1)	ES2161187B1 (de)
FI (1)	FI19992648L (de)
GB (1)	GB2341319B (de)
HU (1)	HUP0003034A2 (de)
ID (1)	ID23516A (de)
IL (2)	IL133396A0 (de)
IS (1)	IS5289A (de)
LT (1)	LT4714B (de)
LV (1)	LV12490B (de)
NO (1)	NO996117L (de)
NZ (1)	NZ501669A (de)
OA (1)	OA11307A (de)
PL (1)	PL196256B1 (de)
RO (1)	RO121252B1 (de)
SI (1)	SI20191A (de)
SK (1)	SK172299A3 (de)
TN (1)	TNSN98086A1 (de)
TR (1)	TR200000540T2 (de)
WO (1)	WO1998056325A1 (de)
YU (1)	YU66099A (de)
ZA (1)	ZA984649B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070212402A1 (en) *	2003-12-05	2007-09-13	Rooven Qainton V	Patch

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0399765A2 (de) *	1989-05-22	1990-11-28	Advanced Polymer Systems, Inc.	System zur transdermalen Arzneimittelverabreichung
US5624912A (en) *	1991-08-21	1997-04-29	Burcoglu; Arsinur	Method of treating HIV infection and related secondary infections with defibrotide
WO1997022248A1 (en) *	1995-12-15	1997-06-26	Cryopreservation Technologies Cc	Composition for organ cryopreservation and treatment of viral and bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE60941B1 (en) *	1986-07-10	1994-09-07	Elan Transdermal Ltd	Transdermal drug delivery device
US4855294A (en) *	1988-09-06	1989-08-08	Theratech, Inc.	Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) *	1989-02-23	1996-07-09	University Of Utah	Percutaneous drug delivery system
ES2115756T3 (es) *	1992-02-20	1998-07-01	Merrell Pharma Inc	Derivados de acido sulfonico utilizados en el tratamiento de enfermedades virales.

1998
- 1998-05-29 ZA ZA9804649A patent/ZA984649B/xx unknown
- 1998-06-09 WO PCT/US1998/011956 patent/WO1998056325A1/en active IP Right Grant
- 1998-06-09 EP EP98926488A patent/EP1011567A1/de not_active Withdrawn
- 1998-06-09 KR KR1019997011724A patent/KR20010013709A/ko not_active Application Discontinuation
- 1998-06-09 EA EA200000011A patent/EA200000011A1/ru unknown
- 1998-06-09 TR TR2000/00540T patent/TR200000540T2/xx unknown
- 1998-06-09 CA CA002295176A patent/CA2295176A1/en not_active Abandoned
- 1998-06-09 CZ CZ0447399A patent/CZ298510B6/cs not_active IP Right Cessation
- 1998-06-09 SK SK1722-99A patent/SK172299A3/sk unknown
- 1998-06-09 ES ES009950072A patent/ES2161187B1/es not_active Expired - Lifetime
- 1998-06-09 GB GB9929189A patent/GB2341319B/en not_active Expired - Fee Related
- 1998-06-09 IL IL13339698A patent/IL133396A0/xx active IP Right Grant
- 1998-06-09 CN CN98806085A patent/CN1260703A/zh active Pending
- 1998-06-09 AU AU78315/98A patent/AU7831598A/en not_active Abandoned
- 1998-06-09 BR BR9810095-5A patent/BR9810095A/pt not_active Application Discontinuation
- 1998-06-09 NZ NZ501669A patent/NZ501669A/en unknown
- 1998-06-09 EE EEP199900562A patent/EE9900562A/xx unknown
- 1998-06-09 AP APAP/P/1999/001708A patent/AP1629A/en active
- 1998-06-09 YU YU66099A patent/YU66099A/sh unknown
- 1998-06-09 PL PL338439A patent/PL196256B1/pl unknown
- 1998-06-09 JP JP50311899A patent/JP4531141B2/ja not_active Expired - Fee Related
- 1998-06-09 RO RO99-01313A patent/RO121252B1/ro unknown
- 1998-06-09 ID IDW20000042A patent/ID23516A/id unknown
- 1998-06-09 SI SI9820040A patent/SI20191A/sl unknown
- 1998-06-09 HU HU0003034A patent/HUP0003034A2/hu unknown
- 1998-06-11 AR ARP980102783A patent/AR012970A1/es not_active Application Discontinuation
- 1998-06-12 TN TNTNSN98086A patent/TNSN98086A1/fr unknown
1999
- 1999-12-08 IS IS5289A patent/IS5289A/is unknown
- 1999-12-09 FI FI992648A patent/FI19992648L/fi unknown
- 1999-12-09 IL IL133396A patent/IL133396A/en not_active IP Right Cessation
- 1999-12-10 OA OA9900279A patent/OA11307A/en unknown
- 1999-12-10 NO NO996117A patent/NO996117L/no not_active Application Discontinuation
- 1999-12-13 BG BG103997A patent/BG103997A/xx unknown
- 1999-12-20 LT LT99-148A patent/LT4714B/lt not_active IP Right Cessation
2000
- 2000-02-02 LV LVP-99-182A patent/LV12490B/en unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0399765A2 (de) *	1989-05-22	1990-11-28	Advanced Polymer Systems, Inc.	System zur transdermalen Arzneimittelverabreichung
US5624912A (en) *	1991-08-21	1997-04-29	Burcoglu; Arsinur	Method of treating HIV infection and related secondary infections with defibrotide
WO1997022248A1 (en) *	1995-12-15	1997-06-26	Cryopreservation Technologies Cc	Composition for organ cryopreservation and treatment of viral and bacterial infections

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of WO9856325A1 *
VIZA, D. ET AL.: "HHV-6 inhibition by two polar compounds", ANTIVIRAL RESEARCH, vol. 18, no. 1, 1992, pages 27 - 38, XP000876979 *
VIZA, DIMITRI ET AL.: "chemical inducers of cell differentiation inhibit HIV in vitro", AIDS-FORSCHUNG, vol. 4, no. 7, 1989, pages 349 - 352, XP000876957 *

Also Published As

Publication number	Publication date
LV12490A (en)	2000-06-20
ES2161187B1 (es)	2003-08-16
LT4714B (lt)	2000-10-25
BG103997A (en)	2001-07-31
AU7831598A (en)	1998-12-30
KR20010013709A (ko)	2001-02-26
TNSN98086A1 (fr)	2005-03-15
AP9901708A0 (en)	1999-12-31
LT99148A (lt)	2000-07-25
PL196256B1 (pl)	2007-12-31
AP1629A (en)	2006-07-11
NO996117D0 (no)	1999-12-10
IL133396A0 (en)	2001-04-30
CZ298510B6 (cs)	2007-10-24
ID23516A (id)	2000-04-27
GB2341319A (en)	2000-03-15
NO996117L (no)	2000-02-11
CA2295176A1 (en)	1998-12-17
BR9810095A (pt)	2001-11-13
JP2002511862A (ja)	2002-04-16
HUP0003034A2 (hu)	2000-12-28
CZ9904473A3 (cs)	2001-03-14
WO1998056325A1 (en)	1998-12-17
EP1011567A1 (de)	2000-06-28
GB9929189D0 (en)	2000-02-02
JP4531141B2 (ja)	2010-08-25
IL133396A (en)	2006-10-05
CN1260703A (zh)	2000-07-19
NZ501669A (en)	2001-09-28
TR200000540T2 (tr)	2000-09-21
IS5289A (is)	1999-12-08
ZA984649B (en)	1999-12-17
YU66099A (sh)	2002-10-18
SK172299A3 (en)	2000-09-12
SI20191A (sl)	2000-10-31
FI19992648L (fi)	2000-02-03
EA200000011A1 (ru)	2000-08-28
EE9900562A (et)	2000-06-15
AR012970A1 (es)	2000-11-22
OA11307A (en)	2003-10-24
RO121252B1 (ro)	2007-02-28
LV12490B (en)	2000-12-20
ES2161187A1 (es)	2001-11-16
PL338439A1 (en)	2000-11-06
GB2341319B (en)	2002-02-27

Publication	Publication Date	Title
FI972579L (fi)	1997-06-17	Emättimensisäisesti käytettävät lääkkeen vapauttamislaitteet 17 beta-estradioliprekursoreiden antamiseksi
EE05506B1 (et)	2012-02-15	Ravimi manustamise vahend eriti progestiinide jastrogeenide manustamiseks
DE69832298D1 (de)	2005-12-15	Gerät zur kontrollierten abgabe von pharmazeutischen und medizinischen produkten
FR2732223B1 (fr)	1997-06-13	Composition pharmaceutique pour administration transdermique
DZ2494A1 (fr)	2003-01-25	Composition pharmaceutique d'oméprazole.
NO20074774L (no)	1996-12-17	Blandinger omfattende DNA-odeleggende midler og P53
MA26790A1 (fr)	2004-12-20	Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
DE69807634D1 (de)	2002-10-10	Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
MA26456A1 (fr)	2004-12-20	Formulations pharmaceutiques pour la distribution prolongee de medicament.
DZ1877A1 (fr)	2002-02-17	Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
DZ2600A1 (fr)	2003-03-01	Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation.
FI963883L (fi)	1996-09-27	Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
IL127572A (en)	2003-04-10	Pharmaceutical composition and medicament for nasal administration
MA27076A1 (fr)	2004-12-20	Regime de dosage et composition pharmaceutique pour contraception d'urgence
EP1165597A4 (de)	2003-06-11	Bifunktionale moleküle zur verabreichung therapeutisch wirksamer stoffe
CA2268305A1 (en)	1998-04-23	Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
CA2120062A1 (en)	1994-11-11	Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
FI970331L (fi)	1997-01-27	Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
FR2735132B1 (fr)	1998-04-24	Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
FR2796287B1 (fr)	2006-01-20	Dispositif d'administration de medicament
FR2660192B1 (fr)	1995-02-03	Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
EP1011567A4 (de)	2000-06-28	Arzneistoffabgabesysteme und verfahren zur behandlung viraler und mikrobieller infektionen und des abmagerungssyndroms
DZ2564A1 (fr)	2003-02-15	Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.
FR2718024B1 (fr)	1996-06-21	Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2747018B1 (fr)	1998-05-15	Dispositif therapeutique de substitution et/ou d'inhalation, notamment pour les fumeurs

Legal Events

Date	Code	Title	Description
2000-05-12	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-06-28	17P	Request for examination filed	Effective date: 19991210
2000-06-28	A4	Supplementary search report drawn up and despatched	Effective date: 20000321
2000-06-28	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-02-28	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: VIRODENE PHARMACEUTICAL HOLDINGS (PTY) LTD.
2003-05-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2003-07-09	18D	Application deemed to be withdrawn	Effective date: 20030102